Cormorant Capital
11
107M
9
0.18
7
- Stages of investment
- Areas of investment
Summary
The main office of represented Corporate Investor is situated in the New York. The venture was found in North America in United States.
The important activity for fund was in 2019. The higher amount of exits for fund were in 2019. Comparing to the other companies, this Cormorant Capital performs on 4 percentage points more the average number of lead investments. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of more than 100 millions dollars.
We can highlight the next thriving fund investment areas, such as Life Science, Biopharma. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline BridgeBio, CMAB BioPharm, Cabaletta Bio
The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Cormorant Capital, startups are often financed by Third Rock Ventures, The Column Group, Kohlberg Kravis Roberts. The meaningful sponsors for the fund in investment in the same round are Viking Global Investors, Perceptive Advisors, Kohlberg Kravis Roberts.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 0
- Exits
- 7
- Follow on index
- 0.18
- Investments by industry
- Biotechnology (9)
- Medical (7)
- Life Science (5)
- Pharmaceutical (4)
- Health Care (3) Show 5 more
- Investments by region
-
- United States (9)
- Switzerland (1)
- China (1)
- Peak activity year
- 2019
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 78M
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
- Avg. multiplicator
- 0.95
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Terremoto Biosciences | 02 Nov 2023 | Early Stage Venture | 175M | United States, California, San Francisco |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.